Login / Signup

Estimating the cost of regulating genome edited crops: expert judgment and overconfidence.

Rim LassouedPeter W B PhillipsStuart J SmythHayley Hesseln
Published in: GM crops & food (2019)
Experts are often called on to inform decision makers with subjective estimates of uncertain events. Their judgment serves as the basis for policy-related decision-making. This paper analyzes survey results used to collect experts' opinions of the likely cost to bring genome edited crops to market. We also examine the effect of expertise (scientific experts versus social scientists in plant biotechnology) and possible knowledge mis-calibration, both in terms of overconfidence (i.e., when subjective knowledge is inflated) and under-confidence (i.e., when subjective knowledge is deflated), on the estimation of cost involved in the development and commercial release of genome edited crops. We found that the expected costs of genome edited crops are case specific and depend on whether crops will likely be regulated as genetically modified or accepted as conventional varieties and not subject to any regulatory oversight by federal regulators. While cost evaluation of genome edited crops did not vary among scientific and social experts, it did vary among domains of knowledge. Hence, expert's performance can be described as task-specific in the context of this study.
Keyphrases
  • crispr cas
  • healthcare
  • decision making
  • genome wide
  • mental health
  • transcription factor
  • public health
  • clinical practice
  • gene expression
  • cross sectional
  • depressive symptoms
  • physical activity
  • drug induced
  • cell wall